• Introduction to Large Language...

*Result*: Introduction to Large Language Models (LLMs) for dementia care and research.

Title:
Introduction to Large Language Models (LLMs) for dementia care and research.
Authors:
Treder MS; School of Computer Science & Informatics, Cardiff University, Cardiff, United Kingdom., Lee S; Olive AI Limited, London, United Kingdom., Tsvetanov KA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Department of Psychology, University of Cambridge, Cambridge, United Kingdom.
Source:
Frontiers in dementia [Front Dement] 2024 May 14; Vol. 3, pp. 1385303. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918787575706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-3919 (Electronic) Linking ISSN: 28133919 NLM ISO Abbreviation: Front Dement Subsets: PubMed not MEDLINE
Imprint Name(s):
Original Publication: [Lausanne, Switzerland] : Frontiers Media SA, [2022]-
References:
NPJ Digit Med. 2023 Jul 6;6(1):120. (PMID: 37414860)
Proc Conf Empir Methods Nat Lang Process. 2023 Dec;2023:7129-7143. (PMID: 38213944)
AMIA Annu Symp Proc. 2024 Jan 11;2023:1105-1114. (PMID: 38222348)
Nature. 2023 Aug;620(7972):172-180. (PMID: 37438534)
Curr Alzheimer Res. 2018;15(2):130-138. (PMID: 29165085)
Lang Linguist Compass. 2021 Aug;15(8):e12432. (PMID: 35864931)
Exp Gerontol. 2022 Aug;165:111852. (PMID: 35644416)
Alzheimers Dement. 2018 Apr;14(4):535-562. (PMID: 29653606)
Curr Opin Ophthalmol. 2022 Sep 1;33(5):425-431. (PMID: 35916570)
Korean J Radiol. 2023 Aug;24(8):715-718. (PMID: 37500572)
J Alzheimers Dis. 2022;90(2):513-528. (PMID: 36120780)
World J Psychiatry. 2016 Mar 22;6(1):7-17. (PMID: 27014594)
Front Psychiatry. 2021 Feb 18;12:615754. (PMID: 33679476)
EBioMedicine. 2021 Oct;72:103600. (PMID: 34614461)
Alzheimers Dement. 2023 Dec;19(12):5885-5904. (PMID: 37563912)
Brain. 2020 May 1;143(5):1555-1571. (PMID: 32438414)
Alzheimers Res Ther. 2023 Feb 10;15(1):32. (PMID: 36765411)
Psychogeriatrics. 2019 May;19(3):264-275. (PMID: 30548731)
Neurobiol Aging. 2019 Jun;78:98-110. (PMID: 30925302)
PLOS Digit Health. 2022 Dec 22;1(12):e0000168. (PMID: 36812634)
Eur J Neurol. 2018 Jan;25(1):59-70. (PMID: 28872215)
Indian J Dermatol. 2016 Jul-Aug;61(4):385-92. (PMID: 27512183)
Front Psychol. 2021 Feb 18;11:612771. (PMID: 33679498)
EClinicalMedicine. 2022 Jul 22;51:101580. (PMID: 35898316)
Brain Pathol. 2024 May;34(3):e13207. (PMID: 37553205)
Am J Psychiatry. 2017 Apr 1;174(4):329-340. (PMID: 27838936)
J Glob Health. 2019 Dec;9(2):020310. (PMID: 31777656)
AMIA Annu Symp Proc. 2017 Feb 10;2016:496-503. (PMID: 28269845)
Brain Inform. 2022 Jul 26;9(1):17. (PMID: 35882684)
J Gerontol Nurs. 2015 Oct;41(10):46-56. (PMID: 26488255)
JMIR Aging. 2022 Mar 31;5(1):e35677. (PMID: 35290197)
Radiology. 2019 Feb;290(2):456-464. (PMID: 30398430)
Brain Lang. 1987 May;31(1):122-37. (PMID: 2437993)
Neurology. 2007 Dec 11;69(24):2197-204. (PMID: 17568013)
PLoS One. 2019 May 24;14(5):e0217388. (PMID: 31125389)
Perspect Med Educ. 2023 Jun 29;12(1):261-270. (PMID: 37397181)
Lancet Public Health. 2022 Feb;7(2):e105-e125. (PMID: 34998485)
Multimed Tools Appl. 2023;82(3):3713-3744. (PMID: 35855771)
JMIR Med Inform. 2021 Dec 24;9(12):e28632. (PMID: 34951601)
J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):135-42. (PMID: 23232034)
Nat Commun. 2022 Jun 20;13(1):3404. (PMID: 35725739)
Disabil Rehabil Assist Technol. 2024 Jul;19(5):2131-2132. (PMID: 37697967)
NPJ Digit Med. 2020 Jul 30;3:99. (PMID: 32821854)
ASSETS. 2022 Oct;2022:. (PMID: 37283282)
Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2215907120. (PMID: 36943882)
Reprod Biomed Online. 2023 Jul;47(1):3-9. (PMID: 37142479)
Lancet. 2020 Aug 8;396(10248):413-446. (PMID: 32738937)
J Biomed Inform. 2022 Mar;127:104030. (PMID: 35183766)
Healthcare (Basel). 2021 Aug 12;9(8):. (PMID: 34442173)
J Alzheimers Dis. 2021;83(3):1073-1087. (PMID: 34397414)
Dementia (London). 2020 Feb;19(2):148-181. (PMID: 31920117)
Ther Adv Neurol Disord. 2013 Sep;6(5):337-8. (PMID: 23997818)
J Med Internet Res. 2023 Jul 25;25:e48966. (PMID: 37490317)
Assist Technol. 2023 May 4;35(3):248-257. (PMID: 34919023)
Am J Geriatr Psychiatry. 2019 Apr;27(4):363-377. (PMID: 30581140)
J Med Internet Res. 2023 Jun 14;25:e47184. (PMID: 37314848)
IEEE Trans Vis Comput Graph. 2023 Apr;29(4):2146-2165. (PMID: 35007194)
Front Aging Neurosci. 2018 Jun 12;10:172. (PMID: 29946252)
J Neurol. 2016 Nov;263(11):2339-2354. (PMID: 27372450)
J Am Med Inform Assoc. 2024 Apr 13;:. (PMID: 38613821)
Camb Prism Precis Med. 2022 Dec 06;1:e9. (PMID: 38550934)
J Alzheimers Dis. 2019;68(4):1587-1601. (PMID: 30958360)
J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105864. (PMID: 34062312)
J Ambient Intell Humaniz Comput. 2022 Apr 29;:1-16. (PMID: 35529905)
Neurol Clin Pract. 2024 Feb;14(1):e200223. (PMID: 38152063)
Neuron. 2024 Mar 6;112(5):698-717. (PMID: 38340718)
Acta Neuropathol. 2017 Aug;134(2):171-186. (PMID: 28488154)
J Alzheimers Dis. 2020;78(4):1547-1574. (PMID: 33185605)
Curr Opin Psychiatry. 2022 Mar 1;35(2):123-129. (PMID: 34861656)
Sci Rep. 2024 May 4;14(1):10273. (PMID: 38704403)
Neurol Clin. 2017 May;35(2):339-374. (PMID: 28410663)
Front Comput Neurosci. 2015 Jun 02;9:66. (PMID: 26082713)
Science. 2023 Jul 14;381(6654):adj5957. (PMID: 37440662)
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Sep;6(9):856-864. (PMID: 33571718)
Clin Geriatr Med. 2014 Aug;30(3):421-42. (PMID: 25037289)
Can J Psychiatry. 2019 Jul;64(7):456-464. (PMID: 30897957)
J Neurol Neurosurg Psychiatry. 2020 Nov 20;:. (PMID: 33219045)
Alzheimers Dement (N Y). 2017 Jun 21;3(3):385-392. (PMID: 29067344)
Aging Ment Health. 2021 Mar;25(3):575-584. (PMID: 31851830)
Neurology. 2016 May 3;86(18):1736-43. (PMID: 27037234)
Nat Med. 2024 Apr;30(4):1134-1142. (PMID: 38413730)
Alzheimers Dement. 2023 Apr;19(4):1598-1695. (PMID: 36918389)
J Gerontol B Psychol Sci Soc Sci. 2017 Sep 01;72(5):742-751. (PMID: 28329835)
Front Aging Neurosci. 2016 Apr 26;8:84. (PMID: 27199734)
J Med Internet Res. 2022 Mar 10;24(3):e27791. (PMID: 35266875)
Brief Bioinform. 2023 Nov 22;25(1):. (PMID: 38168838)
Front Neurosci. 2018 Aug 06;12:525. (PMID: 30127711)
J Biomed Inform. 2023 Aug;144:104442. (PMID: 37429512)
J Am Coll Cardiol. 2019 Jul 2;73(25):3326-3344. (PMID: 31248555)
Psychiatry Clin Neurosci. 2023 Nov;77(11):592-596. (PMID: 37612880)
J Alzheimers Dis. 2024;97(2):559-565. (PMID: 38143345)
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:4409-4413. (PMID: 31946844)
Contributed Indexing:
Keywords: Alzheimer's disease; Artificial Intelligence; Large Language Model (LLM); care; dementia; natural language processing
Entry Date(s):
Date Created: 20240731 Latest Revision: 20240801
Update Code:
20260130
PubMed Central ID:
PMC11285660
DOI:
10.3389/frdem.2024.1385303
PMID:
39081594
Database:
MEDLINE

*Further Information*

*Introduction: Dementia is a progressive neurodegenerative disorder that affects cognitive abilities including memory, reasoning, and communication skills, leading to gradual decline in daily activities and social engagement. In light of the recent advent of Large Language Models (LLMs) such as ChatGPT, this paper aims to thoroughly analyse their potential applications and usefulness in dementia care and research.
Method: To this end, we offer an introduction into LLMs, outlining the key features, capabilities, limitations, potential risks, and practical considerations for deployment as easy-to-use software (e.g., smartphone apps). We then explore various domains related to dementia, identifying opportunities for LLMs to enhance understanding, diagnostics, and treatment, with a broader emphasis on improving patient care. For each domain, the specific contributions of LLMs are examined, such as their ability to engage users in meaningful conversations, deliver personalized support, and offer cognitive enrichment. Potential benefits encompass improved social interaction, enhanced cognitive functioning, increased emotional well-being, and reduced caregiver burden. The deployment of LLMs in caregiving frameworks also raises a number of concerns and considerations. These include privacy and safety concerns, the need for empirical validation, user-centered design, adaptation to the user's unique needs, and the integration of multimodal inputs to create more immersive and personalized experiences. Additionally, ethical guidelines and privacy protocols must be established to ensure responsible and ethical deployment of LLMs.
Results: We report the results on a questionnaire filled in by people with dementia (PwD) and their supporters wherein we surveyed the usefulness of different application scenarios of LLMs as well as the features that LLM-powered apps should have. Both PwD and supporters were largely positive regarding the prospect of LLMs in care, although concerns were raised regarding bias, data privacy and transparency.
Discussion: Overall, this review corroborates the promising utilization of LLMs to positively impact dementia care by boosting cognitive abilities, enriching social interaction, and supporting caregivers. The findings underscore the importance of further research and development in this field to fully harness the benefits of LLMs and maximize their potential for improving the lives of individuals living with dementia.
(Copyright © 2024 Treder, Lee and Tsvetanov.)*

*SL was employed by Olive AI Limited. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.*